Aclaris Therapeutics's market cap is currently $244.83M. The company's EPS TTM is $-0.13; its P/E ratio is -1.65; Aclaris Therapeutics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
